In Vivo vs Ex Vivo Delivery: Innovations in Viral and Non-Viral...

bir ses eklendi Health

2025-11-21 06:18:48 -

In Vivo vs Ex Vivo Delivery: Innovations in Viral and Non-Viral Vectors Critical for Advancing Gene Therapy Effectiveness

The **gene editing market** is defined not only by scientific breakthroughs but also by a highly complex and often contentious **intellectual property (IP) landscape**. The core technologies, particularly those related to CRISPR-Cas systems, are subject to extensive patent litigation and cross-licensing agreements that dictate which companies can legally commercialize which applications in...

0 Yorumlar 0 hisse senetleri 8 Views 0 önizleme